EQUISOCK: New Antiequine
NCT: NCT07333768 · NOT_YET_RECRUITING
Brief Summary
The goal of this experimental study is to test the feasibility and validity of a new orthosis in patients with ankle lesions (external popliteal sciatic nerve or nerve injuries resulting in loss of ankle dorsiflexion) of both sexes and all ages. The main question it aims to answer is:Is the new orthosis a support for ankle stability??Does the new orthosis improve ankle function and patients' quality of life??The control group will be the subjects themselves when wearing their conventional ankle orthosis or without it. Participants must wear the new ankle orthosis for at least one month to assess the effectiveness of the orthosis and evaluate any changes that have occurred in the ankle joint and muscles.
Frequently Asked Questions
What is EQUISOCK: New Antiequine?
EQUISOCK: New Antiequine is a clinical trial registered under NCT07333768. Current status: NOT_YET_RECRUITING.
What is the status of NCT07333768?
The current status of NCT07333768 (EQUISOCK: New Antiequine) is: NOT_YET_RECRUITING.
When did EQUISOCK: New Antiequine start?
EQUISOCK: New Antiequine started on 2026-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.